Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Daaboul, Yazan [1 ]
Rowin, Ethan [2 ]
Maron, Martin [2 ]
Kimmelstiel, Carey [1 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 80卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-355
引用
收藏
页码：B144 / B144
页数：1
相关论文
共 50 条
  • [41] Reduction in mitral regurgitation after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Crawford, FA
    Nielsen, C
    Fernandes, V
    Frankis, M
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 146A - 146A
  • [42] REAL WORLD EXPERIENCE OF THE USE OF MAVACAMTEN IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Reza, Nosheen
    Marzolf, Amy B.
    Hornsby, Nicole
    Vann, Laura C.
    De Feria, Alejandro
    Owens, Anjali Tiku
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 322 - 322
  • [43] Septal ablation for hypertrophic obstructive cardiomyopathy: An analysis of the patients with dissatisfactory reduction of the outflow gradient
    Faber, L
    Werlemann, B
    Krater, L
    Seggewiss, H
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 200A - 200A
  • [44] Sex Differences In Characteristics Of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Initiated On Mavacamten
    Duqueney, Estherland
    Reza, Nosheen
    Boakye, Ellen
    Marzolf, Amy
    Hornsby, Nicole
    DE Feria, Alejandro
    Owens, Anjali
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [45] COVID-19 Impacted Septal Reduction Therapies in Hypertrophic Cardiomyopathy
    Desai, Spandan
    Roma, Nicholas
    Pattoli, Megan
    Durkin, Matthew
    Shah, Kashyap
    Amaratunga, Eluwana
    Magid, Lindsey
    Yellapu, Vikas
    Shirani, Jamshid
    CIRCULATION, 2024, 150
  • [46] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [47] A novel hybrid approach to nonsurgical septal reduction in hypertrophic obstructive cardiomyopathy
    Bezgin, Tahir
    Celik, Aziz Inan
    Baytugan, Nart Zafer
    Cagdas, Metin
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2024, 82 (10): : 1013 - 1014
  • [48] Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
    Lakkis, NM
    Nagueh, SF
    Kleiman, NS
    Killip, D
    He, ZX
    Verani, MS
    Roberts, R
    Spencer, WH
    CIRCULATION, 1998, 98 (17) : 1750 - 1755
  • [49] Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
    Sedehi, Daniel
    Finocchiaro, Gherardo
    Tibayan, Yen
    Chi, Jeffrey
    Pavlovic, Aleksandra
    Kim, Young M.
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Woo, Joseph
    Ha, Richard
    Lee, David P.
    Ashley, Euan A.
    JOURNAL OF CARDIOLOGY, 2015, 66 (1-2) : 57 - 62
  • [50] Electrophysiologic consequences of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (11) : 1296 - 1296
12345